Trial intelligence / Profile preview

API-KNEE: Catheter-based Anesthesia After TKA

NCT03372265Phase 4Completed

Sponsor
Nordsjællands Hospital
Start
Dec 2017
Primary completion
Feb 2019
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Nordsjællands Hospital. Started Dec 2017; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03372265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03372265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call